SCHEMBL18350128

SCHEMBL18350128

c1ccc2c(c1)oc1ccc3sc4ccc5oc6ccccc6c5c4c3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 5/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ PGAM1 P18669 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ GPR3 P46089 1/20 0.41
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16919420 0.93 GPR3 (0.45) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL17930626 0.90 GPR3 (0.46) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL16919549 0.88 MAPT (0.39) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL16919551 0.85 GPR3 (0.42) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL19108943 0.84 GPR3 (0.41) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL1635475 0.84 MAOA (0.59) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL13935962 0.81 GPR3 (0.45) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL24871152 0.79 AHR (0.41) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL17431201 0.79 MAPT (0.42) MAOAKDM4EALDH1A1MAPTHPGD
SCHEMBL25171452 0.78 MGAM (0.35) MAOAKDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11309496-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-04-19 — — US disclosed
US-20200335704-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-10-22 — — US disclosed
US-10741771-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-08-11 — — US disclosed
US-20160380206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11309496-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof GPX1, LEF1, OCIAD1 MAOA 217/4885KDM4E 1049/4885ALDH1A1 372/4885
US-20160380206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, OCIAD1 MAOA 304/4885KDM4E 897/4885ALDH1A1 480/4885
US-10741771-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof GPX1, OR51E2, OCIAD1 MAOA 304/4885KDM4E 897/4885ALDH1A1 480/4885
US-20200335704-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF GPX1, LEF1, OCIAD1 MAOA 217/4885KDM4E 1049/4885ALDH1A1 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback